STI-1558 clinical trials
Also written STI-1558.
How each study uses STI-1558 is sorted by a rule, right about nine times in ten. Readers can ask us to read every study one by one.Ask us to read each study
Approvals
The first approval found in each region, with its record
- United States
- Not in FDA's approval records
- European Union
- Not in EMA's list of EU-wide authorizations
From FDA's Drugs@FDA and Purple Book (through openFDA) and the European Medicines Agency, files of Sept 2026 and 27 Oct 2026. National approvals in Europe and other countries are not included. How this is worked out
How studies write it
Studies that test it under each name
Development codes
- STI-1558
- 5
Studies by the year they started
6 studies that test it; most in 2023 (4)
| Year | Studies |
|---|---|
| 2022 | 2 |
| 2023 | 4 |
By phase
A phase 1/2 study counts in both.
What it is tested for
Each study’s main condition, where its own words name it, so a study counts once.
Who runs them
Industry 6 · Other 0
Zhejiang ACEA Pharmaceutical Co. Ltd. (5) · Sorrento Therapeutics, Inc. (1)
Studies
Open first, then newest update. How each study uses STI-1558 is read from its arms, and is right about nine times in ten. Ask us to read each study. These are the studies that list it as an intervention; a search of ClinicalTrials.gov also finds studies that mention it only in a description, such as earlier treatment.
Testing it · 6
- Study to Assess the Efficacy and Safety of STI-1558 in Adult Subjects With Mild or Moderate (COVID-19)CompletedPhase 3Zhejiang ACEA Pharmaceutical Co. Ltd.NCT05716425Written as STI-1558How we know
- A Bioequivalence Trial of Fasting Single Oral STI-1558 Capsule in Healthy Chinese SubjectsCompletedPhase 1Zhejiang ACEA Pharmaceutical Co. Ltd.NCT06044233Written as STI-1558How we know
- A Study to Evaluate the Relative Bioavailability of STI-1558 and the Effect of Itraconazole and Rifampin on the Pharmacokinetics of STI-1558CompletedPhase 1Zhejiang ACEA Pharmaceutical Co. Ltd.NCT05685719Written as STI-1558How we know
- [14C] Study on Mass Balance and Biotransformation of STI-1558 in Healthy Chinese Adult Male SubjectsCompletedPhase 1Zhejiang ACEA Pharmaceutical Co. Ltd.NCT05754411Written as [14C]STI-1558How we know
- Safety and Efficacy Study of STI-1558 in Healthy Adults and SARS-CoV-2-Positive PatientsCompletedPhase 1Zhejiang ACEA Pharmaceutical Co. Ltd.NCT05523739Written as STI-1558How we know
- Study to Assess the Safety, Tolerability and Pharmacokinetics of STI-1558 in Healthy VolunteersCompletedPhase 1Sorrento Therapeutics, Inc.NCT05364840Written as STI-1558How we know